相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A BAFF/APRIL axis regulates obesogenic diet-driven weight gain
Calvin C. Chan et al.
NATURE COMMUNICATIONS (2021)
Do different bariatric surgical procedures influence plasma levels of matrix metalloproteinase-2, -7, and -9 among patients with type 2 diabetes mellitus?
Wen-Chi Wu et al.
WORLD JOURNAL OF DIABETES (2020)
Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis
Olivier Govaere et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Chitinase-3 like-protein-1 function and its role in diseases
Ting Zhao et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Serum biomarkers of fibrosis and extracellular matrix remodeling in patients with nonalcoholic fatty liver disease: association with liver histology
Yusuf Yilmaz et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2019)
Behavior of Metalloproteinases in Adipose Tissue, Liver and Arterial Wall: An Update of Extracellular Matrix Remodeling
Gabriela Berg et al.
CELLS (2019)
Beneficial Effect of Bariatric Surgery on Abnormal MMP-9 and AMPK Activities: Potential Markers of Obesity-Related CV Risk
Concha F. Garcia-Prieto et al.
FRONTIERS IN PHYSIOLOGY (2019)
Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease
Chiara Rosso et al.
JOURNAL OF HEPATOLOGY (2019)
The Long Pentraxin PTX3 as a Link Between Innate Immunity, Tissue Remodeling, and Cancer
Andrea Doni et al.
FRONTIERS IN IMMUNOLOGY (2019)
TNFR1 and TNFR2 in the Control of the Life and Death Balance of Macrophages
Harald Wajant et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
Associations between infra-pancreatic fat deposition and circulating levels of cytokines
Ruma G. Singh et al.
CYTOKINE (2019)
Nonalcoholic Fatty Pancreas Disease
Nihar Shah et al.
NUTRITION IN CLINICAL PRACTICE (2019)
Comparative analysis of obesity-related cardiometabolic and renal biomarkers in human plasma and serum
Meenu Rohini Rajan et al.
SCIENTIFIC REPORTS (2019)
Shining LIGHT on the metabolic role of the cytokine TNFSF14 and the implications on hepatic IL-6 production
Bernadette M. Saunders et al.
IMMUNOLOGY AND CELL BIOLOGY (2018)
An Integrated View of Immunometabolism
Yun Sok Lee et al.
CELL (2018)
Multiomics biomarkers for the prediction of nonalcoholic fatty liver disease severity
Carlos J. Pirola et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Fatty pancreas: A possible risk factor for pancreatic cancer in animals and humans
Mami Takahashi et al.
CANCER SCIENCE (2018)
Paracrine and endocrine actions of bone-the functions of secretory proteins from osteoblasts, osteocytes, and osteoclasts
Yujiao Han et al.
BONE RESEARCH (2018)
Prevalence of Fatty Liver Disease and Hepatic Iron Overload in a Northeastern German Population by Using Quantitative MR Imaging
Jens-Peter Kuehn et al.
RADIOLOGY (2017)
Ectopic fat accumulation in the pancreas and its biomarkers: A systematic review and meta-analysis
Ruma G. Singh et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2017)
Serum Pentraxin 3 Fragment as a Noninvasive Marker of Nonalcoholic Fatty Liver Disease in Obese Children and Adolescents
Rasha Tarif Hamza et al.
HORMONE RESEARCH IN PAEDIATRICS (2016)
Reduced circulating levels of sTWEAK are associated with NAFLD and may affect hepatocyte triglyceride accumulation
J. Lozano-Bartolome et al.
INTERNATIONAL JOURNAL OF OBESITY (2016)
How to diagnose NAFLD in 2016
E. Bugianesi et al.
JOURNAL OF HEPATOLOGY (2016)
The macrophage activation marker sCD163 is associated with morphological disease stages in patients with non-alcoholic fatty liver disease
Konstantin Kazankov et al.
LIVER INTERNATIONAL (2016)
Gastric bypass-induced weight loss alters obesity-associated patterns of plasma pentraxin-3 and systemic inflammatory markers
Rocco Barazzoni et al.
SURGERY FOR OBESITY AND RELATED DISEASES (2016)
Soluble CD163 is increased in patients with acute pancreatitis independent of disease severity
Thomas Karrasch et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2015)
Plasma Pentraxin 3 Differentiates Nonalcoholic Steatohepatitis (NASH) from Non-NASH
Salih Boga et al.
METABOLIC SYNDROME AND RELATED DISORDERS (2015)
Pancreatic Steatosis Demonstrated at MR Imaging in the General Population: Clinical Relevance
Jens-Peter Kuehn et al.
RADIOLOGY (2015)
Circulating Soluble CD163 is Associated with Steatohepatitis and Advanced Fibrosis in Nonalcoholic Fatty Liver Disease
Jessica L. Mueller et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2015)
Intrahepatic Fat Content Correlates with Soluble CD163 in Relation to Weight Loss Induced by Roux-en-Y Gastric Bypass
Karen Fjeldborg et al.
OBESITY (2015)
Effect of insulin-resistance on circulating and adipose tissue MMP-2 and MMP-9 activity in rats fed a sucrose-rich diet
V. Miksztowicz et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2014)
Inflammatory Biomarker Pentraxin 3 (PTX3) in Relation to Obesity, Body Fat Depots and Weight Loss
Anna Witasp et al.
OBESITY (2014)
Higher hepatic gene expression and serum levels of matrix metalloproteinase-2 are associated with steatohepatitis in non-alcoholic fatty liver diseases
Hidenori Toyoda et al.
BIOMARKERS (2013)
Regional Differences in Islet Distribution in the Human Pancreas - Preferential Beta-Cell Loss in the Head Region in Patients with Type 2 Diabetes
Xiaojun Wang et al.
PLOS ONE (2013)
TWEAK: a new player obesity and diabetes
Joan Vendrell et al.
FRONTIERS IN IMMUNOLOGY (2013)
Relationship between monocyte/macrophage activation marker soluble CD163 and insulin resistance in obese and normal-weight subjects
Markella V. Zanni et al.
CLINICAL ENDOCRINOLOGY (2012)
Soluble CD163
Holger J. Moller
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2012)
Reporting FDR analogous confidence intervals for the log fold change of differentially expressed genes
Klaus Jung et al.
BMC BIOINFORMATICS (2011)
Serum Soluble CD163 Predicts Risk of Type 2 Diabetes in the General Population
Holger J. Moller et al.
CLINICAL CHEMISTRY (2011)
Soluble CD163 is not increased in visceral fat and steatotic liver and is even suppressed by free fatty acids in vitro
Sabrina Bauer et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2011)
Cohort Profile: The Study of Health in Pomerania
Henry Voelzke et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2011)
LIGHT (TNFSF14) inhibits adipose differentiation without affecting adipocyte metabolism
G. Tiller et al.
INTERNATIONAL JOURNAL OF OBESITY (2011)
Quantification of human body fat tissue percentage by MRI
Hans-Peter Mueller et al.
NMR IN BIOMEDICINE (2011)
Plasma soluble tumour necrosis factor-α receptor 2 is elevated in obesity: specific contribution of visceral adiposity
Amelie Cartier et al.
CLINICAL ENDOCRINOLOGY (2010)
LIGHT is associated with hypertriglyceridemia in obese subjects and increased cytokine secretion from cultured human adipocytes
J. Bassols et al.
INTERNATIONAL JOURNAL OF OBESITY (2010)
Determination of physiological plasma pentraxin 3 (PTX3) levels in healthy populations
Kazumi Yamasaki et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2009)
Effects of TWEAK (TNF Superfamily Member 12) on Differentiation, Metabolism, and Secretory Function of Human Primary Preadipocytes and Adipocytes
Gabriele Tiller et al.
ENDOCRINOLOGY (2009)
Adiponectin downregulates CD163 whose cellular and soluble forms are elevated in obesity
D. Sporrer et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2009)
Diminished upregulation of visceral adipose heme oxygenase-1 correlates with waist-to-hip ratio and insulin resistance
S. Shakeri-Manesch et al.
INTERNATIONAL JOURNAL OF OBESITY (2009)
Whole-Body Magnetic Resonance Imaging of Healthy Volunteers: Pilot Study Results from the Population-Based SHIP Study
K. Hegenscheid et al.
ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN (2009)
Matrix metalloproteinase-2 and-9 levels in obese patients
G. Derosa et al.
ENDOTHELIUM-JOURNAL OF ENDOTHELIAL CELL RESEARCH (2008)
Adipocyte produces matrix metalloproteinases 2 and 9 -: Involvement in adipose differentiation
A Bouloumié et al.
DIABETES (2001)
分享论文
